Close Menu

NEW YORK (GenomeWeb) – Genome analysis company Genomics plc said today that it has closed a £25 million ($32.5 million) Series B funding round.

Vertex Pharmaceuticals led the round with a £10.5 million equity investment as part of a new, multiyear R&D partnership with Genomics. The IP Group, Woodford Investment Management, Invesco Perpetual, Oxford Sciences Innovation, Lansdowne Partners, and Tanarra also participated in the Series B.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.